OncoImmunology
Volume 9, 2020 - Issue 1
Open access
4,027
Views
46
CrossRef citations to date
0
Altmetric
Back Matter
Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
Sonja C. S. Simona Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, GermanyCorrespondence[email protected]
View further author information
, View further author information
Xiaoying Hua Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, GermanyView further author information
, Jasper Pantenc Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany;d Research Group Hematopoietic and Leukemic Stem Cells, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, GermanyView further author information
, Mareike Greesa Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
https://orcid.org/0000-0001-9095-8762View further author information
Simon Rendersc Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany;d Research Group Hematopoietic and Leukemic Stem Cells, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, GermanyView further author information
, Daniel Thomasa Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, GermanyView further author information
, Rebekka Webera Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany;e Faculty of Biosciences, Ruprecht-Karl University of Heidelberg, Heidelberg, GermanyView further author information
, Torsten J. Schulzef Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;g Department of Diagnostics, Institute Springe, Springe, GermanyView further author information
, Jochen Utikala Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, GermanyView further author information
& Viktor Umanskya Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;b Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, GermanyView further author information
show all
Article: 1727116
|
Received 13 May 2019, Accepted 06 Dec 2019, Published online: 15 Feb 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.